Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PRESEPT Study: Prospective Evaluation of Septin 9 Performance for Colorectal Cancer Screening

NCT00855348 is registered in ClinicalTrials.gov with Epigenomics, Inc as lead sponsor.

NCT NCT00855348
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00855348 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PRESEPT Study: Prospective Evaluation of Septin 9 Performance for Colorectal Cancer Screening
Lead sponsor
Epigenomics, Inc
Phase
Observational
Overall status
Completed
Start date
June 30, 2008
Completion date
April 30, 2010
Enrollment
7,929 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer